USANA Q1 net sales up 10% to $250M; EPS down 43% to $0.49; reiterates FY outlook

USANA HEALTH SCIENCES INC

2025-Q1 EPS reported $0.49 revenue$249,539,000

Net sales $250M (+10% YoY); net earnings $9.4M (-43%); diluted EPS $0.49 vs $0.86.
Adjusted diluted EPS $0.73 (-15%); adjusted EBITDA $30M (-10%).
Direct selling Active Customers 459,000 (-7%); Hiya Active Monthly Subscribers 224,000.
FY2025 outlook reaffirmed: consolidated net sales $920M-$1.0B, diluted EPS $1.50-$2.20.
Repurchased 399,000 shares for $12M; $49M remaining under authorization.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.